• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: April 30-May 4, 2012

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

April 30-May 4, 2012
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs4/30/12Los Angeles, CAN/AN/AAccelerating Innovation in the Medical Industry
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs5/2/12Washington, DCN/AN/AReception Honoring the Work of the Treatment Action Group
John M. Taylor, III, J.D., Counselor to the Commissioner4/30/12-5/4/12N/AN/AN/ANo Significant Meetings
Deborah M. Autor, Esq., Deputy Commissioner for Global Regulatory Operations and Policy5/2/12Washington, DCCarolyn BeckerSeveral representatives from the U.S. Government and IndustrySafeguarding Intellectual Property and Preventing Corruption in Global Markets Roundtable Discussion
Deborah M. Autor, Esq., Deputy Commissioner for Global Regulatory Operations and Policy5/3/12Washington, DCN/AN/A2012 International AntiCounterfeiting Coalition Annual Spring Conference
Dara A. Corrigan, Associate Commissioner for Regulatory Affairs4/30/12-5/4/12N/AN/AN/ANo Significant Meetings
Virginia Cox, Associate Commissioner for External Affairs4/30/12-5/4/12N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products4/30/12-5/4/12 N/AN/AN/ANo Significant Meetings
Elizabeth H. Dickinson, Esq., Chief Counsel4/30/12-5/4/12N/AN/AN/ANo Significant Meetings
David Dorsey, J.D., Acting Associate Commissioner for Policy and Planning4/30/12-5/4/12N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine5/3/12Lancaster, PAJason Dreabit, Dan McChesney, Randy Gnatt, John Mussman, Alfan Dangin, Gabe Davila, Geoffrey Wong, Cindy Burnsteel, Tim Schell, Beilei Ge, Laurie HannaN/AFacility Tour of Pennfield Feed Mill
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health4/30/12-5/4/12 N/AN/AN/ANo Significant Meetings
Michael M. Landa, Director, Center for Food Safety and Applied Nutrition4/30/12-5/4/12N/AN/AN/ANo Significant Meetings 
Walter Harris, Chief Operating Officer4/30/12-5/4/12N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research4/30/12-5/4/12N/AN/AN/ANo Significant Meetings
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health5/1/12Silver Spring, MDElizabeth Mansfield, Barbara  Abrams, Alberto GutierrezPaul Sheives (Biotechnology Industry Organization); Todd Gillenwater (California Healthcare Institute); Jamie K. Wolszon (Hyman, Phelps & McNamara, P.C.)Research Use Only Products
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research5/4/12-5/6/12Xi'an City, ChinaN/AN/ASpeech at International Association of Neurorestoratology V and 9th Global College of Neuroprotection & Neuroregeneration Conference with the International Spinal Cord Injury Treatments & Trials Symposium
Stephen Spielberg, M.D., Ph.D., Deputy Commissioner for Medical Products and Tobacco5/1/12Washington, DCN/AN/A5th Annual FDA/ Medical Technology Learning Institute Medical Device and In Vitro Diagnostics Statistical Issues Workshop
Stephen Spielberg, M.D., Ph.D., Deputy Commissioner for Medical Products and Tobacco5/2/12Baltimore, MDN/AN/ALife Sciences Advisory Board
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods5/2/12College Park, MDJulie MossWilliam Friedman (Covington & Burling LLP)Food Safety Modernization Act
Mary Lou Valdez, Associate Commissioner for International Programs5/2/12-5/4/12Seattle, WAKatherine BondSeveral representatives from The Pan American Health Organization (PAHO) and The Gates Foundation-Global Health Product ForumGlobal Health Product Forum on the PAHO Regional Platform for Access and Innovation for Health Technologies
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs4/30/12-5/4/12N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research5/2/12Parsippany, NJN/ADavid Holveck (Endo Pharmaceuticals); Robert Hugin (Celgene Corporation); Clive Meanwell (The Medicines Company)Rebuilding Pharma A Different Way
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research5/3/12New York, NYN/AThomas Insel (National Institute of Mental Health); Shitij Kapur (King's College London); Susan Dentzer (Health Affairs); Mikael Dolsten (Pfizer)Alexandria Summit Neuroscience 2012 Annual Meeting
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research5/4/12-5/6/12Greenwich, CTN/AFrancis Collins (National Institutes of Health); Michale Rawlins (NICE); John Lechleiter (Eli Lilly); Mikael Dolsten (Pfizer); Martin Mackay (Astra Zeneca); Gary Neil (Johnson & Johnson)Pharma Times HEVER Conference